AMGN Amgen
$402.60 -0.09%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.09%
YTD
+36.20%
P/E
25.09
P/B
20.36
ROE
89.3%
Div yield
3.2%
Beta
0.5
Market cap
$219.3B
RSI (14)
47
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$403.30
Close
$402.60
VWAP (n/a)
—
Day high
$405.00
Day low
$396.01
Volume
2.0M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance · Oct 6
Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
Yahoo Finance · Oct 4
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
Yahoo Finance · Oct 1
Recombinant Proteins Market - Global Strategic Business Report: Sales Hit to $5.8 Billion by 2030 - Benchmark Thermo Fisher Scientific, Merck KGaA, Amgen, Bio-Techne and GenScript Biotech Amid Tariff Disruption
Yahoo Finance · Sep 30
Why Amgen’s 6% Dividend Raise Masks a Tougher Road Ahead
Yahoo Finance · Sep 29
Amgen (AMGN) Has a New Growth Opportunity. But How Much Is It Really Worth?
Yahoo Finance · Sep 29
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 5, 2026 View → 8-K Aug 4, 2026 View → 8-K Jul 31, 2026 View → 8-K May 20, 2026 View → 8-K May 19, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell AMGN. Try it in the Lab to size a position and see the risk.